PL EN

Aktualności

EMEA: Guideline on the data to be provided in support of a request to include a substance in the list of substances considered as not falling within the scope of regulation (EC) No 470/2009

19.11.2009
This guideline contains guidance relating to the data to be provided in support of a request for the CVMP to consider the inclusion of an excipient in the list of substances considered as not ...

EMEA: Reflection paper on risk management plans for centrally authorised veterinary medicinal products

19.11.2009
Veterinary pharmacovigilance is in continuous development. The provision for risk management systems is new in the field of veterinary medicines and therefore gives opportunity for novel, targeted ...

EMEA: Concept paper on the development of a guideline on similar biological medicinal products containing monoclonal antibodies

19.11.2009
This guideline lays down the non-clinical and clinical requirements for monoclonal antibody-containing medicinal products claiming to be similar to another one already marketed, i.e. similar ...

EMEA: Overview of comments received on draft guideline on similar biological medicinal products containing low-molecular-weight-heparins

19.11.2009
The guidance is limited to non-clinical and clinical aspects and does not address the Quality Standard aspects that biosimilar products must adhere to. This may be misunderstood as “the quality ...

EMEA: Draft community herbal monograph

19.11.2009
Draft community herbal monograph on Agni casti fructus Vitex agnus castus L., fructus (agnus castus) ...

EMEA: Reflection paper in the Extrapolation of results from clinical studies conducted outside europe to the eu-population

19.11.2009
This reflection paper, including experience from a sample of applications, shows that in particular extrinsic factors, such as medical practice, disease definition and study population, ...

EMEA: Draft guideline on medicinal products for the treatment of insomnia

19.11.2009
The present document should be considered as general guidance on the development for medicinal products for the treatment of acute and chronic forms of insomnia. Its main focus is on ...

EMEA: Overview of comments received on the draft guideline on the development of New Medicinal Products for the Treatment of Smoking

19.11.2009
SRNT Europe, representing European scientists in the field of nicotine and tobacco research, is concerned that this guideline in its present form will be a barrier to the development of new ...

MHRA: MHRA Patient Information Quality Unit performance figures

19.11.2009
MHRA is now publishing performance figures for the Patient Information Quality Unit (PIQU).This follows feedback from the medicines trades associations that separate metrics are needed to aid ...

MHRA: Guidance published on UK exporting of medicines

19.11.2009
Guidance helping pharmaceutical manufacturers and distributors to meet their obligations about the supply of medicines, has been jointly published today by nine health organisations including the ...

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny